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A previous report from our group had shown in vitro a 
direct interaction between peroxidases and dietary anti-
oxidants at physiological concentrations, where in the 
absence of H2O2, the antioxidants could serve as oxidiz-
ing substrates for the peroxidases. However, the physi-
ological relevance of those findings had not been evalu-
ated. The main objective of this study was to determine 
whether the oxidizing products produced in the interac-
tion between peroxidase and gallic acid at a physiologi-
cal concentration of 1 μM may promote cell death or 
survival in a human microvascular endothelial cell line 
(HMEC-1). Our findings suggested that gallic acid may 
show a double-edged sword behaviour, since in the ab-
sence of H2O2 it may have a pro-oxidant effect which 
may promote cell injury (evidenced by LDH, Crystal Vio-
let and calcein AM viability/citotoxicity assays), while in 
the presence of H2O2, gallic acid may act as an antioxi-
dant inhibiting oxidative species produced in the peroxi-
dase cycle of peroxidases. These observations were con-
firmed with several oxidative stress biomarkers and the 
evaluation of the activation of cell survival pathways like 
AKT and MAPK/ERK. 
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InTRODuCTIOn
There is now increasing experimental and clinical evi-
dence showing involvement of oxidative stress in the 
pathogenesis of atherosclerosis (Harrison et al., 2003; 
Yokoyama, 2004).  It is well known that during endothe-
lial inflammation with activated macrophages several re-
active intermediates (e.g., hypochlorus acid, chloramines, 
tyrosyl radicals and nitrogen dioxide) produced by the 
interaction between myeloperoxidase (MPO) and hy-
drogen peroxide may promote the oxidation of lipopro-
teins (Heinecke, 2003). Inmunohistochemical assays have 
shown the presence of MPO in human atherosclerotic 
lesions, thus implicating them in in vivo LDL modifica-
tion and atherogenesis (Daugherty et al., 1994). At least 
three mechanisms involved in MPO-induced vascular 
injury responses have been described: consumption of 
nitric oxide, oxidation of LDL, and reaction with L-
arginine and protein to produce endogenous nitric ox-
ide synthase inhibitors (Lee et al., 2009; Royet al., 2009; 
Schindhelm et al., 2009). All these mechanisms are hy-
drogen peroxide-dependent. Therefore, several studies 
have been undertaken to understand the mechanism of 
this process and to propose actions that may inhibit the 
oxidative compounds produced within this system.
In this context, polyphenol intake has been related 
with the prevention of atherome plaque formation, 
since they may act as antioxidants and anti-inflammatory 
agents in vivo (Grassi et al., 2009; Hu, 2009). However, 
their molecular actions in cardiovascular disease preven-
tion are not fully understood yet. It is suggested that fla-
vonoids may act as co-substrates of MPO in the pres-
ence of H2O2, resulting in the formation of oxidized fla-
vonoids possibly by two sequential one-electron reduc-
tion steps, generating compound II and the ferric form 
of MPO (Shiba et al., 2008). However, the role of those 
oxidized flavonoids in human pathology is still a focus 
of discussion.  In addition, a strong inhibitory effect of 
quercetin aglycone on the MPO-catalyzed oxidation re-
action has been demonstrated in vitro (Pincemail et al., 
1988; Kato et al., 2003), which may reduce the formation 
of oxidizing compounds. It has also been demonstrated 
that gallates may strongly inhibit the enzyme activity, al-
beit out concentrations higher (around 30 μM to 40 μM) 
than physiological ones (Kato et al., 2003; Rosso et al., 
2006).  On this basis it is plausible that the inhibition of 
MPO activity by polyphenols might be one mechanism 
for the prevention of cardiovascular disease.
Nevertheless, even if increasing evidence supports 
the role of oxidation in atherogenesis, the protective ef-
fect of dietary antioxidants in the human is still debated 
and controversial. The LDL resistance to oxidation does 
not systematically correlate with its antioxidant content; 
the degree of lipid peroxidation in atherosclerotic tissue 
also fails to correlate with the extent of lesion forma-
tion, while considerable amounts of antioxidants can be 
observed in atherosclerotic lesions (Witting et al., 1999). 
In this context the in vitro results from our group may 
explain a double-edged sword behaviour of dietary anti-
oxidants in their interaction with peroxidases, where in 
the absence of hydrogen peroxide or organic hydroper-
oxides the peroxidases may use dietary antioxidants as 
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oxidizing substrates to induce oxidation of other organic 
molecules (Serrano et al., 2009). However, the physiologi-
cal relevance of these findings is unknown. 
On the basis of this information, the main objective 
of this study was to determine the physiological implica-
tions of the oxidizing products generated in the interac-
tion between peroxidases and gallic acid, at a physiologi-
cal concentration of 1 μM, in the absence of hydrogen 
peroxide in a human microvascular endothelial cell line 
(HMEC-1).  Crystal Violet toxicology assay, Calcein AM 
viability/cytotoxicity assay and lactate dehydrogenase 
activity were evaluated to determine cell survival under 
these conditions as well as the activation of AKT and 
MAPK/ERK cell survival pathways. Furthermore, oxida-
tive stress biomarkers like carbonyl adducts, neuroketals, 
MDA-lysine adducts and carboxymethyl lysine adducts 
were determined under this conditions. 
MATERIALs AnD METHODs
Materials. Gallic acid monohydrate (328225) and 
Crystal Violet (C0775) were purchased from Sigma-
Aldrich. Lactate dehydrogenase (LDH) was measured 
with the CytoTox 96® non-radioactive cytotoxicity assay 
from Promega (Madison, WI, USA). Calcein AM (C3099) 
was purchased from Molecular Probes.  Horseradish per-
oxidase (HRP) (A-12216) was purchased from Molecular 
Probes.  Primary antibodies for Western blotting are de-
scribed in Table 1. For cell culture, human microvascular 
endothelial cell line (HMEC-1) was kindly provided by 
Dr. Anne Négre-Salvayre (INSERM, Toulouse, France). 
DMEM (BE12-614F) was purchased from BioWhittaker. 
MEM (51200), FBS (10270-106), penicillin and strepto-
mycin (15140) and l-glutamine (25030) were purchased 
from Gibco.
Cell culture. HMEC-1 is an immortalized human 
microvascular endothelial cell line that retains the mor-
phologic, phenotypic, and functional characteristics of 
normal human microvascular endothelial cells (Ades et 
al., 1992). HMEC-1 cells were grown in DMEM supple-
mented with 10 % fetal bovine serum, 2 mM l-glutamine 
and penicillin/streptomycin (1 000 U/mL and 1000 μg/L 
respectively). Cells were maintained at 37 ºC in a hu-
midified atmosphere of 5 % CO2. In all experiments cells 
were grown until confluence and then transferred to 6- 
or 96-well plates. 
Calcein AM viability assay. Calcein AM viability 
assay is based on the principle that live cells are dis-
tinguished by the presence of ubiquitous intracellular 
esterase activity, determined by the enzymatic conver-
sion of nonfluorescent cell-permeant calcein AM to the 
intensely fluorescent calcein (excitation/emission 495 
nm/515 nm) (Papadopoulus et al., 1994). For the vi-
ability assay HMEC-1 cells were grown until confluence 
in DMEM 10 % fetal bovine serum and transferred to 
a 96-well plate and maintained for 24 h in MEM sup-
plemented with 0.5 % fetal bovine serum. Twelve wells 
were used per experimental treatment which included: 
control, gallic acid 1 μM, HRP (2 U/mL) + gallic acid 
1 μM and each of these three groups with H2O2 (200 
μM). All compounds were suspended in MEM without 
phenol red and without fetal bovine serum.  After 24 h 
of incubation in their corresponding experimental treat-
ment, 100 μL of working solution containing 2 µM cal-
cein AM was added to each well and then incubated at 
room temperature for 45 min. Fluorescence (excitation/
emission 495/515) was measured for the determination 
of live cells. Cell viability was determined by comparing 
the values of calcein fluorescence with those for control 
cells. 
Crystal Violet assay. HMEC-1 cells were cultured 
and treated following the same procedure employed in 
the calcein AM viability assay described above. After 
24 h of incubation with the corresponding experimen-
tal treatment, the medium was removed and cells were 
washed with 200 µL of PBS and then incubated for 20 
min with Crystal Violet (0.2 %). After incubation, plates 
were rinsed with tap water and 100 µL of sodium do-
decyl sulphate (1 %) was added and the absorbance of 
each well was measured using a microplate reader at 
570 nm. Cell viability was determined by comparing the 
absorbance reading relative to control treatment.
LDH-based toxicity assay.  HMEC-1 cells were 
cultured and treated following the same procedure em-
ployed in the calcein AM viability assay described above. 
After 24 h of incubation with the corresponding experi-
mental treatment, 10 μL of lysis solution was added to 
6 of 12 wells in each group, and 10 μL of Hanks bal-
anced solution to the other 6 wells in each group. The 
wells where Hanks balanced solution was added served 
to measure the amount of LDH released in the medium, 
and the wells where the lysis solution was added served 
to measure the total LDH content (culture-released and 
intracellular). After 30 min of incubation 50 μL of the 
supernatant was transferred to an enzymatic assay plate, 
50 μL of LDH substrate mix was added and incubated 
for 30 min at room temp., protected from light. Later 50 
μL of stop solution (1 M acetic acid) was added to each 
well and the absorbance was recorded at 490 nm. Cell 
viability was measured by relating the content of LDH 
in the supernatant and to that after lysis.
Analysis of oxidative stress markers and cell sur-
vival pathways. Oxidative lesions were evaluated by 
western blot using anti-DNP (carbonyl adducts forma-
tion), N-epsilon-(carboxymethyl) lysine (CML), neuroket-
al-adducted proteins and malondialdehyde-lysine (MDA-
lys) adducts. The activation of AKT and MAPK/ERK 
were used to measure the activation of cell survival path-
ways. Proteasomal stress was measured by the activa-
Table 1. Primary and secondary antibodies used for Western 
blot immunodetection
Antigen Supplier Dilution
DNP Sigma 1:2000
CML Transgenic 1:1000
Neuroketals Abcam 1:500
MDA-lys Biomedical company 1:300
AKT Biosource 1:1000
p-AKT Cell signaling 1:1000
MAPK/ERK Cell signaling 1:1000
p-MAPK/ERK Cell signaling 1:1000
Ubiquitin Sigma 1:100
eIF2α Abcam 1:1000
p-eIF2α Cell signaling 1:1000
β-Actin Sigma 1:3000
Anti-mouse IgG Amersham 1:30000
Anti-rabbit IgG Pierce 1:100000
Anti-goat IgG Vector 1:15000
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tion of eIF2α and the degree of protein ubiquitination. 
HMEC-1 cells were incubated as described above for 
cell viability determination in 6-well plates. After treat-
ments, cells were lysed using RIPA buffer with protease 
and phosphatase inhibitors. Protein concentrations were 
measured using the Lowry assay (BioRad Laboratories, 
München, Germany) with bovine serum albumin as a 
standard. Total protein (15–40 μg) was resolved by SDS-
PAGE and electroblotted onto polyvinylidene difluo-
ride membranes (Immobilon-P Millipore, Bedford, MA, 
USA). Immunodetection was performed using as prima-
ry and secondary antibodies those listed in Table 1. A 
monoclonal antibody to β-actin (Sigma, USA) was used 
to control protein loading. Protein bands were visual-
ised with the chemiluminescence ECL method (Millipore 
Corporation, Billerica, MA, USA). Luminescence was 
recorded and quantified in a Lumi-Imager equipment 
(Boehringer, Mannheim, Germany), using the Quantity 
One 4.6.5. software.
Statistical analysis. All statistics were performed us-
ing the SPSS software (SPSS Inc., Chicago, IL, USA). 
Differences between groups were analyzed by one way 
Anova. The 0.05 level was selected as the point of mini-
mal statistical significance in every comparison.
REsuLTs
In vitro toxicity assays
Three in vitro toxicity assays were employed to asses 
the effects of oxidative agents produced by the in-
teraction of peroxidase and gallic acid as shown in 
Fig. 1. The experimental model included the incuba-
tion of HMEC-1 cells for 24 h with gallic acid (1 μM) 
and its combination with HRP peroxidase in the pres-
ence or absence of H2O2.  The three viability/toxicity 
assays employed showed almost the same results. In 
all cases, gallic acid seem to induce cell survival/pro-
liferation, while HRP did not induce any effect on cell 
survival/proliferation as observed by the calcein AM 
and LDH toxicity assay.  It is also evidenced that the 
protecting effect of gallic acid in HMEC-1 cells could 
be counteracted by the incorporation of HRP peroxi-
dase in the system.
As negative controls cells were cultured with high 
amounts of H2O2 (200 μM) to induce cell injury. In the 
three viability/toxicology assays tested the cell viability 
was reduced considerably by the addition of H2O2 to the 
medium (Fig. 1). The addition of HRP or gallic acid in-
hibited the cell injury induced by H2O2, however, their 
beneficial effects were lost when both HRP and gallic 
acid were added. 
MAPK/ERK and AKT pathway analysis
Cell survival pathways were assessed to confirm the 
results obtained by the toxicity assays.  The MAPK/
ERK pathway is a signal transduction pathway that 
couples intracellular responses to the binding of 
growth factors to cell surface receptors. In the same 
manner, AKT is involved in cellular survival path-
ways, by inhibiting apoptotic processes. Results from 
the analysis of these pathways are shown in Fig. 2. 
As controls for the inhibition of these pathways, the 
incubation of the cell line under high concentration of 
H2O2 (200 μM) which is assumed to induce cell death 
was employed. The activity of both pathways was re-
duced considerably under the treatment with H2O2. 
Under the experimental conditions studied, the treat-
ment with gallic acid and HRP combined in the ab-
sence of H2O2 reduced considerably the activation of 
both cell survival pathways, which resembles the re-
sults obtained in cell toxicology assays. The inhibition 
of the MAPK/ERK pathway by gallic acid + HRP 
peroxidase was similar to the inhibition observed in 
the control group exposed to high concentration of 
H2O2 (200 μM) and with a major extent reduction in 
the AKT pathway signalling.
Oxidative stress biomarkers
Oxidative stress is also known to induce apopto-
sis in a variety of cell types by activating intracellular 
cell death signalling cascades (Martindale & Holbrook, 
2002). The purpose of assessing oxidative stress was 
Figure 1. Effects of HRP, gallic acid and H2O2 on viability of 
HMEC-1 cell culture.
Cell viability was measured by (A) Crystal Violet assay, (B) calcein 
AM cytotoxicity assay, and (C) LDH release to cell culture medium. 
Same letters between columns shows no statistically significant 
differences between groups (P > 0.05).
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to determine if the observed effects in the loss of cell 
survival could be attributed to the oxidative damage 
produced by the interaction between HRP and gal-
lic acid.  Four oxidative stress biomarkers were as-
sessed as shown in Fig. 3. The results obtained were 
similar to those of the toxicity assays and cell survival 
pathways in the case of three (CML, MDA-lys and 
neuroketals) of the four stress biomarkers assessed. 
The experimental conditions (gallic acid + HRP, gal-
lic acid + HRP + H2O2, and control+H2O2) that caused 
a high oxidative stress showed also a high cell death 
rate and a poor activation of cell survival pathways. 
Anti-DNP immunoreactivity showed different results 
in relation to CML, MDA-lys and neuroketals oxida-
tive stress biomarkers principally because it was ob-
served a different oxidized protein pattern between 
treatments (Fig. 4) where an increase in specifics pro-
teins oxidation was detected. Anti-ubiquitin and eIF2α 
immunoreactivy was also evaluated to determine the 
rate of protein turnover, principally to determine 
whether or not the degree of oxidated protein could 
be due to accumulation of damaged proteins because 
of a lower proteosomal activity (Fig. 5). The grade 
of protein ubiquitination was higher when H2O2 was 
present as well as when gallic acid was added in com-
bination with HRP. Increased eIF2α phosphorylation, 
also observed under the latter condition, indicates 
high endoplasmatic reticulum stress which may lead to 
an impairment of the ubiquitin-proteosomal activity. 
Figure 2. Effects of HRP, gallic acid and H2O2 on cell survival 
pathways.
MAPK/ERK (A) and AKT (B) pathways were analysed. Activation 
of these pathways is expressed as an increase in the amount of 
phospho-MAPK/ERK and phospho-AKT in relation to the total 
amount of MAPK/ERK and AKT, respectively. Same letters between 
columns shows no statistically significant differences between 
groups (P > 0.05).
Figure 3. Oxidative damage induced by HRP, gallic acid and 
H2O2 in HMEC-1 cell culture.
(A) Carbonyl adducts measured by dinitrophenyl derivatization, (B) 
Nε-carboxymethyl lysine (CML), (C) neuroketal-adducted proteins 
and (D) malondialdehyde-lysine adducts.  Same letters between 
columns shows no statistically significant differences between 
groups (P > 0.05).
A A
B B
C
D
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DIsCussIOn
The main purpose of this study was to elucidate the 
cellular responses induced by oxidative compounds pro-
duced by peroxidase + antioxidant in the absence of 
H2O2, conditions studied before in vitro (Serrano et al., 
2009). At the cellular level, the oxidant injury produced 
in this system may elicit a wide spectrum of responses 
ranging from proliferation to growth arrest, senescence, 
and cell death (Martindale & Holbrook, 2002; Cully & 
Downward, 2009). In the case of endothelial cells, it 
is well known that excessive activation of the immune 
system during inflammation may cause host cell/tissue 
damage via harmful peroxidase activity and oxidizing 
compound production (Harrison et al., 2003; Yokoyama, 
2004). This experiment was performed to mimic the ef-
fects to endothelial cells of peroxidase activity in the 
presence of antioxidant compounds without an inflam-
matory response.
The doses of peroxidase and gallic acid used were 
physiological (Manach et al., 2005; Mocatta et al., 2007). 
Almost no literature data was found regarding the physi-
ological meaning of this interaction. Some authors have 
suggested that polyphenols may inhibit the enzymatic 
activity of peroxidases (Kato et al., 2003; Rosso et al., 
2006; Shiba et al., 2008), therefore reducing the oxidative 
stress induced by peroxidase by-products. The doses of 
polyphenols employed in those studies were around 40 
μM, considerably higher than the physiological concen-
tration of polyphenols and gallic acid in plasma (0.2 μM 
to 2 μM) (Manach et al., 2005). Moreover, those studies 
were performed on the basis of HOCl or tyrosyl radical 
formation without taking into consideration other oxida-
tion by-products. In addition, previous experiments per-
formed by our group suggest that above 10 μM, gallic 
acid may be toxic to HMEC-1 cell culture reducing con-
siderably its viability. 
Our results suggest that gallic acid with peroxidases 
shows dual behaviour in relation to the presence or ab-
sence of H2O2 in the medium: while in the presence of 
H2O2 it may act as an antioxidant inhibiting the genera-
tion of oxidizing products by HRP-H2O2, in the absence 
of H2O2 it may act as oxidizing compound.
At the cellular level, the oxidative stress produced via 
the peroxidasen-gallic acid system (without H2O2) was 
strong enough to produce oxidant injury to HMEC-1 
cells, and may be responsible for the cell toxicity ob-
served in the toxicity assays employed. The oxidative 
compounds produced in this system are unknown at 
the moment. However, as shown in Fig. 4, the oxida-
tive compounds produced by peroxidase may have spe-
cific protein targets. The oxidative stress induced by 
the peroxidasen-gallic acid interaction (without H2O2) 
was also sufficient to inhibit MAPK/ERK and AKT 
cell survival signals, which may be a consequence of 
high oxidative stress, as evidenced by the oxidation 
biomarkers (MDA-lys, CML and neuroketals) analyzed 
and the high amount of ubiquitinated proteins. In the 
same context the high levels of ubiquitinated proteins 
observed could also be due to a low proteosomal ac-
tivity caused by a high endoplasmatic reticulum stress 
(evidenced by high activation of eIF2α), reducing the 
folding capacity of the endoplasmatic reticulum, which 
results in the accumulation and aggregation of unfolded 
proteins. 
 It could be suggested that the oxidative compounds 
produced by the peroxidasen-gallic acid interaction 
(without H2O2) suffice to induce oxidation damage in 
HMEC-1 cell culture affecting cell functioning. 
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